• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Ailanthone: a new potential drug for castration-resistant prostate cancer.臭椿酮：一种用于去势抵抗性前列腺癌的新型潜在药物。
Chin J Cancer. 2017 Mar 3;36(1):25. doi: 10.1186/s40880-017-0194-7.
2
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.葶苈子酮通过靶向 p23 克服去势抵抗性前列腺癌中 MDV3100 的耐药性。
Nat Commun. 2016 Dec 13;7:13122. doi: 10.1038/ncomms13122.
3
New drug option for men with aggressive prostate cancer.侵袭性前列腺癌男性的新药选择。
Cancer. 2018 Oct 1;124(19):3797. doi: 10.1002/cncr.31753.
4
Therapeutic Discovery for Castration Resistant Prostate Cancer: Patient-derived Xenograft Modelling Brings New Options to the Table.
Eur Urol. 2018 Nov;74(5):573-574. doi: 10.1016/j.eururo.2018.06.049. Epub 2018 Jul 13.
5
Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferation.度他雄胺和恩杂鲁胺协同抑制前列腺肿瘤细胞增殖。
J Urol. 2015 Mar;193(3):1023-9. doi: 10.1016/j.juro.2014.09.021. Epub 2014 Sep 19.
6
Prostate cancer: Revealing mechanisms of resistance.前列腺癌：揭示耐药机制。
Nat Rev Urol. 2018 Mar;15(3):138. doi: 10.1038/nrurol.2018.7. Epub 2018 Jan 23.
7
Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer.恩杂鲁胺：一种用于非转移性去势抵抗性前列腺癌的新适应证。
Asian J Androl. 2019 Mar-Apr;21(2):107-108. doi: 10.4103/aja.aja_88_18.
8
Living Longer and Better with Advanced Prostate Cancer.与晚期前列腺癌相伴，活得更长久、更美好。
Eur Urol. 2020 Sep;78(3):358-359. doi: 10.1016/j.eururo.2020.05.020. Epub 2020 Jun 15.
9
Preclinical toxicology and toxicokinetic evaluation of ailanthone, a natural product against castration-resistant prostate cancer, in mice.苦木苦味素，一种天然产物，用于抗去势抵抗性前列腺癌，在小鼠中的临床前毒理学和毒代动力学评价。
Fitoterapia. 2019 Jul;136:104161. doi: 10.1016/j.fitote.2019.04.016. Epub 2019 Apr 30.
10
Enzalutamide in castration-resistant prostate cancer.恩杂鲁胺治疗去势抵抗性前列腺癌
Lancet Oncol. 2014 Jul;15(8):e312. doi: 10.1016/s1470-2045(14)70251-7.

引用本文的文献

1
The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities.癌症中细胞铁死亡与胞葬作用之间的复杂相互作用：揭示新见解和治疗机会。
Front Oncol. 2024 Oct 31;14:1424218. doi: 10.3389/fonc.2024.1424218. eCollection 2024.
2
The mA regulators in prostate cancer: molecular basis and clinical perspective.前列腺癌中的毫安调节器：分子基础与临床前景
Front Pharmacol. 2024 Aug 29;15:1448872. doi: 10.3389/fphar.2024.1448872. eCollection 2024.
3
Mining bone metastasis related key genes of prostate cancer from the STING pathway based on machine learning.基于机器学习从STING通路挖掘前列腺癌骨转移相关关键基因。
Front Med (Lausanne). 2024 May 21;11:1372495. doi: 10.3389/fmed.2024.1372495. eCollection 2024.
4
Rust Fungi on Medicinal Plants in Guizhou Province with Descriptions of Three New Species.贵州省药用植物上的锈菌及三个新物种的描述
J Fungi (Basel). 2023 Sep 21;9(9):953. doi: 10.3390/jof9090953.
5
Comparative Study of the Lipophilicity of Selected Anti-Androgenic and Blood Uric Acid Lowering Compounds.选定的抗雄激素和降低血尿酸化合物的亲脂性比较研究。
Molecules. 2022 Dec 25;28(1):166. doi: 10.3390/molecules28010166.
6
Ailanthone Inhibits Cell Proliferation in Tongue Squamous Cell Carcinoma via PI3K/AKT Pathway.臭椿酮通过PI3K/AKT信号通路抑制舌鳞状细胞癌的细胞增殖。
Evid Based Complement Alternat Med. 2022 Nov 1;2022:3859489. doi: 10.1155/2022/3859489. eCollection 2022.
7
Physiological and Transcriptomic Analysis of Responses to Ailanthone, a Potential Bio-Herbicide.水黄皮酮（一种有潜力的生物除草剂）响应的生理和转录组学分析。
Int J Mol Sci. 2022 Oct 6;23(19):11854. doi: 10.3390/ijms231911854.
8
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.靶向铁死亡途径以对抗癌症的治疗抗性和转移
Front Pharmacol. 2022 Jun 30;13:909821. doi: 10.3389/fphar.2022.909821. eCollection 2022.
9
Polyphenol Oxidase as a Promising Alternative Therapeutic Agent for Cancer Therapy.多酚氧化酶作为一种有前景的癌症治疗替代药物。
Molecules. 2022 Feb 23;27(5):1515. doi: 10.3390/molecules27051515.
10
Ailanthus Altissima-derived Ailanthone enhances Gastric Cancer Cell Apoptosis by Inducing the Repression of Base Excision Repair by Downregulating p23 Expression.臭椿来源的臭椿酮通过下调 p23 表达抑制碱基切除修复诱导胃癌细胞凋亡。
Int J Biol Sci. 2021 Jul 5;17(11):2811-2825. doi: 10.7150/ijbs.60674. eCollection 2021.

本文引用的文献

1
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.葶苈子酮通过靶向 p23 克服去势抵抗性前列腺癌中 MDV3100 的耐药性。
Nat Commun. 2016 Dec 13;7:13122. doi: 10.1038/ncomms13122.
2
The updated incidences and mortalities of major cancers in China, 2011.2011年中国主要癌症的最新发病率和死亡率。
Chin J Cancer. 2015 Sep 14;34(11):502-7. doi: 10.1186/s40880-015-0042-6.
3
Cancer statistics, 2015.癌症统计数据，2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
4
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.AR-V7 与前列腺癌中对恩杂鲁胺和阿比特龙的耐药性。
N Engl J Med. 2014 Sep 11;371(11):1028-38. doi: 10.1056/NEJMoa1315815. Epub 2014 Sep 3.
5
Lead- and drug-like compounds: the rule-of-five revolution.类铅化合物和类药物化合物：五规则革命
Drug Discov Today Technol. 2004 Dec;1(4):337-41. doi: 10.1016/j.ddtec.2004.11.007.
6
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines.雄激素受体剪接变异体介导恩杂鲁胺在去势抵抗性前列腺癌细胞系中的耐药性。
Cancer Res. 2013 Jan 15;73(2):483-9. doi: 10.1158/0008-5472.CAN-12-3630. Epub 2012 Nov 1.
7
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.在人类前列腺癌中，雄激素受体剪接变体的频繁发生导致去势抵抗。
J Clin Invest. 2010 Aug;120(8):2715-30. doi: 10.1172/JCI41824. Epub 2010 Jul 19.
8
Molecular mechanisms of castration-resistant prostate cancer progression.去势抵抗性前列腺癌进展的分子机制。
Future Oncol. 2009 Nov;5(9):1403-13. doi: 10.2217/fon.09.117.
9
Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells.苦木素类化合物可诱导人体细胞中的线粒体膜去极化和半胱天冬酶3激活。
Cell Death Differ. 2004 Dec;11 Suppl 2:S216-8. doi: 10.1038/sj.cdd.4401534.
10
Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.利用MMTV-荧光素酶报告基因和/或人雄激素受体的腺病毒转导开发两种雄激素受体检测方法用于内分泌筛查。
Toxicol Sci. 2002 Mar;66(1):82-90. doi: 10.1093/toxsci/66.1.82.

Ailanthone: a new potential drug for castration-resistant prostate cancer.

作者信息

Peng Shihong, Yi Zhengfang, Liu Mingyao

机构信息

East China Normal University and Shanghai Fengxian District Central Hospital Joint Center for Translational Medicine, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Rd, Shanghai, 200241, P.R. China.

Department of Molecular and Cellular Medicine, Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M University Health Sciences Center, Houston, TX, 77030, USA.

出版信息

Chin J Cancer. 2017 Mar 3;36(1):25. doi: 10.1186/s40880-017-0194-7.

DOI:10.1186/s40880-017-0194-7
PMID:28257652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5336637/
Abstract
摘要